All posts tagged
Update: After 25 years, MorphoSys Gets its First Antibody Approved
Phase III Success for Janssen and Genmab with Frontline Myeloma Antibody
This Small German Biotech is Dealing with Big Pharma in NASH and Autoimmune Disease
What Cancer Therapies did European Biotechs Showcase at ASCO 2017?
Janssen Stops Phase II Trial for a Danish Blood Cancer Blockbuster
After its First Success, the Virtual Biotech Team is Back at it Again
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
How is European Immuno-Oncology fighting Blood Cancer?
New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira
12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting
Uh-oh, MorphoSys is SUING Competitors over Cancer Antibody Patent!
Collaboration is Key to Microbiomics: New Deal with The Janssen Human Microbiome Institute
Labiotech UG, All Rights Reserved -
Send this to a friend